| |
| Issue |
Title |
| |
| Vol 20, No 3 (2026) |
Assessment of the mortality burden of systemic sclerosis in the Russian Federation: results of a systematic review and meta-regression analysis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
K. V. Sapozhnikov, L. P. Ananyeva, A. M. Lila, L. A. Garzanova, N. A. Sableva, K. A. Katilova, A. A. Lazarev, D. G. Tolkacheva |
| |
| Vol 20, No 3 (2026) |
Association of serum calprotectin with clinical and laboratory manifestations of systemic lupus erythematosus (preliminary data) |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, T. M. Reshetnyak, M. V. Cherkasova, E. N. Vorkel, A. M. Lila |
| |
| Vol 20, No 3 (2026) |
Lupus nephritis in patients from Kyrgyzstan: clinical and laboratory manifestations, disease course variants, and prognostic factors for development |
Abstract
PDF (Rus)
|
|
G. M. Koilubayeva, E. A. Aseeva, S. K. Solovyev, A. M. Lila, D. A. Aiypova, S. I. Glukhova |
| |
| Vol 20, No 3 (2026) |
Ocular involvement in antineutrophil cytoplasmic antibody-associated vasculitis |
Abstract
PDF (Rus)
|
|
T. M. Reshetnyak, E. N. Vorkel, T. A. Lisitsyna, G. A. Davydova, L. A. Kovaleva, M. D. Suprun, K. S. Nurbaeva, A. M. Lila |
| |
| Vol 20, No 3 (2026) |
Approaches to therapy of the metabolic phenotype of osteoarthritis: efficacy of a combination of glucosamine and chondroitin sulfate supplemented with undenatured type 2 collagen, B vitamins, gingerol, and ascorbic acid |
Abstract
PDF (Rus)
|
|
E. A. Strebkova, E. A. Taskina, N. G. Kashevarova, N. M. Savushkina, E. P. Sharapova, T. A. Korotkova, A. R. Khalmetova, D. M. Kudinsky, L. I. Alekseeva, A. M. Lila |
| |
| Vol 20, No 3 (2026) |
Predictors of achieving remission in rheumatoid arthritis during levilimab therapy in real-world clinical practice |
Abstract
PDF (Rus)
|
|
G. F. Fatkhullina, L. A. Latypova, N. M. Taratorkin |
| |
| Vol 20, No 2 (2026) |
Abnormal body composition phenotypes in rheumatoid arthritis: focus on biomarkers of muscle, adipose, and bone tissue |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, M. V. Kozyreva, A. O. Sorokina, N. V. Demin, E. Yu. Samarkina, M. A. Diatroptova, N. V. Toroptsova |
| |
| Vol 20, No 2 (2026) |
Atlantoaxial joint involvement in rheumatoid arthritis: clinical and imaging features |
Abstract
PDF (Rus)
|
|
A. R. Iuskaeva, S. A. Lapshina, R. Z. Abdrakipov, E. V. Sukhorukova, Z. N. Gabdullia, E. S. Zamanova, V. I. Anisimov, E. I. Bogdanov, D. I. Abdulganieva |
| |
| Vol 20, No 2 (2026) |
Assessment of the prevalence of systemic lupus erythematosus in women with reproductive health problems in the Russian Federation. Results of the multicenter pilot PRISMA study |
Abstract
PDF (Rus)
PDF (Eng)
|
|
T. M. Reshetnyak, E. A. Trofimov, D. I. Abdulganieva, A. D. Astakhova, G. R. Enikeeva, N. V. Seredavkina, E. V. Zonova, O. V. Bugrova, M. V. Zlobin, A. A. Klimenko, E. P. Ilivanova, I. A. Ostroushko, S. I. Glukhova, I. V. Pozharov, N. B. Nekrasova, Z. Yu. Mutovina, A. S. Trofimova, S. P. Yakupova, A. E. Remnev, A. M. Lila |
| |
| Vol 20, No 2 (2026) |
Search for significant clinical and imaging criteria for the differential diagnosis of axial spondyloarthritis and axial psoriatic arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. E. Gubar, T. V. Korotaeva, T. V. Dubinina, Yu. L. Korsakova, E. Yu. Loginova, L. D. Vorobyeva, P. O. Tremaskina, E. M. Agafonova, K. V. Sakharova, I. A. Andrianova, A. V. Smirnov, Sh. F. Erdes, M. M. Urumova, S. I. Glukhova |
| |
| Vol 20, No 2 (2026) |
Long-term outcomes of total hip arthroplasty in patients with ankylosing spondylitis |
Abstract
PDF (Rus)
|
|
I. V. Polevoy, A. O. Dubinin, A. A. Roskidailo, M. A. Makarov, A. M. Lila |
| |
| Vol 20, No 2 (2026) |
Efficacy and safety of complex therapy for knee osteoarthritis using a combination of chondroitin sulfate and glucosamine, as well as intra-articular administration of a medical device containing polyacrylamide gel |
Abstract
PDF (Rus)
|
|
A. M. Lila, E. A. Strebkova, E. A. Taskina, N. G. Kashevarova, N. M. Savushkina, E. P. Sharapova, A. R. Khalmetova, T. A. Korotkova, A. B. Demina, E. V. Zonova, A. S. Kabargina, E. P. Trifonova, A. A. Klimenko, D. Yu. Andriyashkina, A. A. Kondrashov, D. V. Somov, M. O. Anishchenko, L. I. Alekseeva, V. A. Lila |
| |
| Vol 20, No 2 (2026) |
Association between interleukin-6 gene polymorphism and age at onset of rheumatoid arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. V. Aboleshina, I. A. Guseva, E. G. Zotkin, E. Yu. Samarkina, N. V. Demidova, A. A. Movsesyan, K. M. Molova, M. A. Makoeva |
| |
| Vol 20, No 1 (2026) |
Analysis of changes in peripheral blood B lymphocyte subpopulations in patients with Sjögren’s disease |
Abstract
PDF (Rus)
|
|
A. V. Torgashina, A. S. Veretennikov, B. D. Chaltsev, Yu. I. Khvan, A. S. Avdeeva, A. P. Aleksankin, D. A. Dibrov |
| |
| Vol 20, No 1 (2026) |
Association between an ability to work and disease activity in patients with axial psoriatic arthritis |
Abstract
PDF (Rus)
|
|
L. D. Vorobyova, T. V. Korotaeva, E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina |
| |
| Vol 20, No 1 (2026) |
Direct interleukin-6 blockade in real-world clinical practice – a path to rationalization of pharmacotherapy and control of rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
P. A. Shesternya, E. M. Aitova, E. N. Alekseev, I. G. Bannikova, E. A. Bogdanova, D. S. Gordeeva, E. O. Dolishnaya, A. Yu. Doroshevskaya, O. B. Ershova, M. V. Zlobin, N. N. Ziablova, L. V. Ivanova, L. A. Knyazeva, E. V. Kryukova, L. V. Masneva, L. I. Myasoutova, I. V. Obukhova, O. N. Odnoshivkina, A. B. Paranuk, I. M. Patrikeeva, T. V. Plaksina, A. S. Povzun, A. V. Rybin, T. S. Sal’nikovа, A. S. Fetisova, N. I. Shpilevaya, A. A. Yakovleva, A. M. Lila |
| |
| Vol 20, No 1 (2026) |
Are we treating rheumatoid arthritis correctly in patients with cardiovascular diseases? At the crossroads of knowledge and opportunities |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. V. Matyanova, E. A. Galushko, E. G. Zotkin |
| |
| Vol 20, No 1 (2026) |
Results of molecular genetic testing in 115 patients with suspected monogenic autoinflammatory disease |
Abstract
PDF (Rus)
|
|
M. F. Beketova, S. O. Salugina, E. S. Fedorov, A. V. Torgashina, E. Yu. Zakharova, N. V. Milovanova, V. V. Shmarin, A. M. Lila |
| |
| Vol 20, No 1 (2026) |
Use of palovarotene in pathogenetic therapy of fibrodysplasia ossificans progressiva: real-world clinical practice experience |
Abstract
PDF (Rus)
PDF (Eng)
|
|
I. P. Nikishina, V. G. Matkava, S. V. Arsenyeva, E. G. Gasymov |
| |
| Vol 20, No 1 (2026) |
Clinical features and prognostic factors associated with neuropsychiatric manifestations of systemic lupus erythematosus in patients of the Kyrgyz population |
Abstract
PDF (Rus)
|
|
G. M. Koilubaeva, T. A. Lisitsyna, E. A. Aseeva, S. K. Solovyev, S. I. Glukhova, A. M. Lila |
| |
| Vol 20, No 1 (2026) |
Molecular mechanisms of taurine effect on the metabolism of blood cells and chondrocytes of knee articular cartilage in patients with late-stage rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
E. V. Chetina, I. G. Kushnareva, M. A. Makarov |
| |
| Vol 20, No 1 (2026) |
Baricitinib in rheumatoid arthritis in real-world clinical practice: pooled analysis of the overall patient cohort and a subgroup of patients with difficult-to-treat disease according to the Moscow registry |
Abstract
PDF (Rus)
|
|
Yu. A. Gavrikova, V. V. Dolgov, E. N. Simonova, A. I. Zagrebneva |
| |
| Vol 20, No 1 (2026) |
Analysis of the structure of use and barriers to access to biologic disease-modifying antirheumantic drugs and selective immunosuppressants in immune-mediated inflammatory rheumatic diseases in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. M. Lila, R. O. Dreval, T. V. Dubinina, M. A. Korolev, D. E. Karateev, V. V. Shipitsyn, P. I. Pchelnikova |
| |
| Vol 20, No 1 (2026) |
Comparative analysis of imaging characteristics of axial spondyloarthritis and axial psoriatic arthritis depending on disease duration |
Abstract
PDF (Rus)
|
|
E. E. Gubar, T. V. Korotaeva, T. V. Dubinina, Yu. L. Korsakova, E. Yu. Loginova, L. D. Vorobyeva, P. O. Tremaskina, E. M. Agafonova, K. V. Sakharova, I. A. Andrianova, A. V. Smirnov, Sh. F. Erdes, M. M. Urumova, S. I. Glukhova |
| |
| Vol 19, No 6 (2025) |
Relationship between pro-inflammatory cytokines and subclinical myocardial dysfunction in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
I. G. Kirillova, A. S. Potapova, A. S. Semashko, T. V. Popkova, M. E. Diatroptov |
| |
| Vol 19, No 6 (2025) |
Bone microarchitecture in rheumatoid arthritis: focus on trabecular bone index |
Abstract
PDF (Rus)
|
|
M. V. Kozyreva, O. A. Nikitinskaya, N. V. Demin, N. V. Toroptsova |
| |
| Vol 19, No 6 (2025) |
Peripheral arterial disease in rheumatology |
Abstract
PDF (Rus)
PDF (Eng)
|
|
N. V. Seredavkina, T. M. Rheshetnyak, S. I. Glukhova, A. M. Lila |
| |
| Vol 19, No 6 (2025) |
Clinical and endoscopic signs of esophageal involvement in patients with systemic sclerosis |
Abstract
PDF (Rus)
|
|
A. I. Dolgushina, G. M. Khusainova, A. O. Khikhlova, A. A. Saenko, O. B. Nesmeyanova, E. R. Olevskaya, M. D. Zagitdinova, S. K. Shty`kov, R. V. Kinzyabulatov |
| |
| Vol 19, No 6 (2025) |
Impact of the extraarticular manifestations on the efficacy and tolerability of seniprutug in radiographic axial spondyloarthritis: post hoc analysis of ELEFTA clinical trial |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. M. Lila, V. I. Mazurov, I. Z. Gaydukova, T. V. Dubinina, A. A. Klimenko, M. A. Korolev, S. A. Lapshina, R. R. Samigullina, E. L. Nasonov, G. A. Vinderskaya, P. S. Pukhtinskaia |
| |
| Vol 19, No 6 (2025) |
Prospective study assessing the effects of the novel pharmaconutraceutical Revocca (unsaponifiable compounds of avocado and soybeans in a 1:2 ratio, rosehip fruit extract, resveratrol, zinc citrate) on the clinical manifestations of osteoarthritis (VECTOR) |
Abstract
PDF (Rus)
|
|
M. A. Lila, E. A. Taskina, E. M. Vukailovich, N. G. Kashevarova, E. A. Strebkova, N. M. Savushkina, E. P. Sharapova, T. A. Korotkova, A. R. Khalmetova, L. I. Alekseeva |
| |
| Vol 19, No 5 (2025) |
Evaluation of the effect of a combination of glucosamine and chondroitin sulfate supplemented with native (undenatured) type 2 collagen, ginger extract, B vitamins, and ascorbic acid on the clinical manifestations of different phenotypes of osteoarthritis |
Abstract
PDF (Rus)
|
|
E. A. Taskina, A. M. Lila, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, N. M. Savushkina, E. P. Sharapova, T. A. Korotkova, A. R. Khalmetova |
| |
| Vol 19, No 5 (2025) |
Correction of vitamin D deficiency in patients with gout receiving febuxostat (pilot study) |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, O. V. Zhelyabina, Ya. I. Kuzmina, M. N. Chikina |
| |
| Vol 19, No 5 (2025) |
Hospital mortality in a cohort of Kyrgyz patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
PDF (Eng)
|
|
G. M. Koilubaeva, E. A. Aseeva, S. K. Soloviev, A. M. Lila, S. I. Glukhova |
| |
| Vol 19, No 5 (2025) |
Early-stage knee osteoarthritis: assessment of structural changes using imaging methods |
Abstract
PDF (Rus)
|
|
A. R. Khalmetova, A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. M. Savushkina, N. G. Kashevarova, E. A. Strebkova, D. M. Kudinsky, O. G. Alekseeva, K. V. Kolesnikova |
| |
| Vol 19, No 5 (2025) |
Slowing the progression of ankylosing spondylitis during long-term therapy with netakimab: results of the international multicenter randomized double-blind phase III clinical trial BCD-085-5/ASTERA |
Abstract
PDF (Rus)
|
|
V. I. Mazurov, A. M. Lila, Sh. F. Erdes, I. Z. Gaydukova, T. V. Dubinina, A. V. Smirnov, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, R. R. Samigullina, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, E. P. Ilivanova, A. V. Strelkova, V. V. Tyrenko, Yu. N. Lin’kova, A. V. Zinkina-Orikhan, E. A. Fokina, A. V. Eremeeva, P. S. Pukhtinskaia |
| |
| Vol 19, No 5 (2025) |
Long-term multicenter observational study of Alflutop in Russia: use in elderly patients with osteoarthritis at various sites (report 5) |
Abstract
PDF (Rus)
|
|
E. A. Taskina, A. M. Lila, T. A. Raskina, L. I. Alekseeva, A. V. Naumov, N. G. Kashevarova |
| |
| Vol 19, No 5 (2025) |
Efficacy and safety of 24-week therapy with a monoclonal antibody to TRBV9+ T lymphocytes (seniprutug) in patients with ankylosing spondylitis: real-world data |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. A. Vasilenko, R. R. Samigullina, A. K. Karibova, Yu. Yu. Grabovetskaya, V. I. Mazurov |
| |
| Vol 19, No 5 (2025) |
Pharmacoeconomic analysis of levilimab use as rheumatoid arthritis therapy in the healthcare system of the Russian Federation |
Abstract
PDF (Rus)
|
|
M. Yu. Frolov, A. M. Lila |
| |
| Vol 19, No 5 (2025) |
CD8+CD28- T lymphocytes as a marker of immunosenescence in patients with late-onset rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
A. V. Aboleshina, A. P. Aleksankin, E. G. Zotkin, A. S. Avdeeva, A. A. Movsesyan, K. M. Molova, M. A. Makoeva |
| |
| Vol 19, No 5 (2025) |
Galectins 1, 3 and 9 in patients with systemic lupus erythematosus: is there an association with disease activity or clinical manifestations? |
Abstract
PDF (Rus)
|
|
L. V. Kondrateva, T. A. Panafidina, Yu. N. Gorbunova, T. V. Popkova, M. E. Diatroptov, A. S. Avdeeva |
| |
| Vol 19, No 5 (2025) |
Clinical significance of urinary soluble CD11b and CD163 receptor levels in ANCA-associated vasculitides |
Abstract
PDF (Rus)
|
|
O. N. Egorova, A. V. Datsina, G. M. Tarasova, E. Yu. Samarkina, N. Yu. Nikishina, S. I. Glukhova, M. E. Diatroptov, A. S. Avdeeva, A. M. Lila |
| |
| Vol 19, No 4 (2025) |
Efficacy, safety, and treatment persistence of netakimab in patients with active psoriatic arthritis in real-world clinical practice: interim results of the post-marketing safety study BCD-085-NIS-03/SIRIUS |
Abstract
PDF (Rus)
|
|
T. V. Korotaeva, O. A. Pritulo, O. B. Nesmeyanova, O. R. Ziganshin, L. L. Rusakova, E. S. Zhugrova, I. M. Marusenko, O. N. Mironenko |
| |
| Vol 19, No 4 (2025) |
Bone mineral density, trabecular bone score, and uric acid in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
M. V. Kozyreva, O. V. Dobrovolskaya, N. V. Demin, N. V. Toroptsova |
| |
| Vol 19, No 4 (2025) |
Rheumatoid arthritis and hyperuricemia: consequences of coexistence |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. V. Matyanova, S. I. Glukhova, E. G. Zotkin |
| |
| Vol 19, No 4 (2025) |
Back pain in patients with rheumatoid arthritis (based on long-term prospective observation) |
Abstract
PDF (Rus)
|
|
P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov |
| |
| Vol 19, No 4 (2025) |
Evolution of osteoarthritis therapy: synergy of combined use of diacerein and chondroitin sulfate |
Abstract
PDF (Rus)
|
|
A. V. Naumov, A. V. Unkovsky, N. O. Khovasova, D. K. Fokeev, D. V. Demenok, A. D. Meshkov |
| |
| Vol 19, No 4 (2025) |
Analysis of the course of immune-mediated inflammatory rheumatic diseases after COVID-19: flare frequency and prognostic determinants |
Abstract
PDF (Rus)
|
|
S. T. Abisheva, A. M. Lila, K. S. Rutskaya-Moroshan |
| |
| Vol 19, No 3 (2025) |
Patient satisfaction with health status in rheumatoid arthritis based on remote assessment: a pilot OPTIMA study (Patient-reported Outcomes, Severity and Medical care in Arthritis) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. Yu. Polishchuk, A. E. Karateev, H. R. Makhmudov, K. S. Kalashnikov, N. A. Bulgakova, A. M. Lila |
| |
| Vol 19, No 3 (2025) |
A prospective study on the effects of glucosamine hydrochloride and chondroitin sulfate combination on systemic inflammation markers in patients with knee osteoarthritis (report 1) |
Abstract
PDF (Rus)
|
|
A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, N. M. Savushkina, N. M. Savushkina, T. A. Korotkova, A. S. Avdeeva, E. Yu. Samarkina, M. E. Diatroptov |
| |
| Vol 19, No 3 (2025) |
On the epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in the adult population of Russia |
Abstract
PDF (Rus)
|
|
O. N. Egorova, A. V. Dacina, G. M. Tarasova, E. Yu. Shukan, A. M. Lila |
| |
| Vol 19, No 3 (2025) |
Factors associated with knee pain at early stages of osteoarthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. R. Khalmetova, Lila A. M., E. A. Taskina, L. I. Alekseeva, N. M. Savushkina, N. G. Kashevarova, E. A. Strebkova, O. G. Alekseeva |
| |
| Vol 19, No 3 (2025) |
Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement |
Abstract
PDF (Rus)
|
|
E. E. Gubar, T. V. Korotaeva, T. V. Dubinina, Yu. L. Korsakova, E. Yu. Loginova, L. D. Vorobyeva, P. O. Tremaskina, E. M. Agafonova, K. V. Sakharova, A. O. Sablina, A. V. Smirnov, Sh. F. Erdes, M. M. Urumova, S. I. Glukhova |
| |
| Vol 19, No 3 (2025) |
Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev |
| |
| Vol 19, No 3 (2025) |
Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real-world clinical practice in Kazakhstan |
Abstract
PDF (Rus)
|
|
G. A. Togizbayev, D. I. Parpiyeva, D. A. Maksot |
| |
| Vol 19, No 3 (2025) |
On the advisability of long-term use of low-dose glucocorticoids in elderly patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. V. Matyanova, E. G. Zotkin, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
Comparison of muscle magnetic resonance imaging data with clinical and laboratory parameters in follow-up of patients with idiopathic inflammatory myopathy |
Abstract
PDF (Rus)
|
|
A. A. Kolomeyichuk, L. P. Ananyeva, A. N. Helkovskaya-Sergeeva, A. D. Koltakova, L. V. Ptichkina, D. O. Kazakov |
| |
| Vol 19, No 2 (2025) |
Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method |
Abstract
PDF (Rus)
PDF (Eng)
|
|
T. M. Reshetnyak, M. V. Cherkasova, F. A. Cheldieva, K. S. Nurbaeva, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence |
Abstract
PDF (Rus)
PDF (Eng)
|
|
P. A. Shesternya, A. I. Zagrebneva, O. V. Antipova, Yu. V. Arbuzova, I. G. Bannikova, L. V. Belozertseva, E. A. Bogdanova, S. A. Bykova, E. A. Vasilenko, I. B. Vinogradova, S. Yu. Davidyan, O. E. Epifanova, E. V. Zemerova, M. V. Zlobin, L. V. Ivanova, N. A. Ilyina, L. V. Ilyushina, E. P. Klyuchnikova, A. V. Makevnina, E. R. Myasoutova, E. E. Nakonechnaya, A. B. Pavlova, T. V. Plaksina, A. V. Rybin, T. S. Salnikova, L. V. Solodovnikova, A. V. Fedorova, I. A. Cherencova, E. V. Jakovleva, S. P. Yakupova, E. N. Alekseev, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study |
Abstract
PDF (Rus)
|
|
M. A. Litvinova, N. M. Bulanov, P. I. Novikov, J. Zhao, D. Munblit, S. V. Moiseev |
| |
| Vol 19, No 2 (2025) |
On the application of the “treat-to-target” strategy and the identification of a cohort of difficult-to-treat patients with rheumatoid arthritis in real-world clinical practice |
Abstract
PDF (Rus)
|
|
O. V. Teplyakova, L. P. Evstigneeva, T. S. Petukhova, E. O. Dolishnaya |
| |
| Vol 19, No 2 (2025) |
Clinical features of systemic lupus erythematosus in men depending on testosterone level |
Abstract
PDF (Rus)
|
|
T. S. Panevin, T. V. Popkova, E. G. Zotkin, S. I. Glukhova, M. E. Diatroptov |
| |
| Vol 19, No 2 (2025) |
Comorbid pathology in patients with late-stage ankylosing spondylitis |
Abstract
PDF (Rus)
|
|
E. S. Yushina, E. V. Zonova, E. B. Luksha, D. N. Orlov, V. V. Rerikh, V. N. Koksharova |
| |
| Vol 19, No 2 (2025) |
The efficacy of colchicine in patients with gout with different missense genetic variants of the ABCG2 gene (V12M; rs2231137 and Q141K; rs2231142) |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, M. N. Chikina, I. A. Guseva, O. V. Zhelyabina, Ya. I. Kuzmina |
| |
| Vol 19, No 2 (2025) |
The efficacy of a complex of vitamins B 1, B6 and B 12 in combination with nonsteroidal antiinflammatory drugs for pain control in osteoarthritis: meta-analysis of randomized controlled trials |
Abstract
PDF (Rus)
|
|
E. S. Filatova, A. E. Karateev, S. I. Glukhova, A. M. Lila |
| |
| Vol 19, No 2 (2025) |
The dose of febuxostat required to achieve the target level of uric acid in patients with normal and impaired renal function |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, M. N. Chikina, O. V. Zhelyabina, Ya. I. Kuzmina |
| |
| Online First |
Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty |
Abstract
PDF (Rus)
|
|
A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev |
| |
| Online First |
Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real clinical practice in Kazakhstan |
Abstract
PDF (Rus)
|
|
G. A. Togizbayev, D. I. Parpiyeva, D. A. Maksot |
| |
| Vol 19, No 1 (2025) |
Experience of using the interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis in real-life clinical practice (based on data from Tyumen Regional Rheumatology Center) |
Abstract
PDF (Rus)
|
|
I. M. Patrikeeva, Yu. A. Lushpaeva, N. V. Knaub, E. A. Ustinova, O. A. Belikov, M. B. Dolgikh, T. Yu. Malysheva |
| |
| Vol 19, No 1 (2025) |
Psychological characteristics of patients with rheumatoid arthritis with severe anxiety and depression |
Abstract
PDF (Rus)
|
|
I. N. Abrosimov, V. M. Yaltonsky, T. A. Lisitsyna, A. A. Abramkin, E. I Lamcheva, A. Yu. Timashkov, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS |
Abstract
PDF (Rus)
PDF (Eng)
|
|
L. P. Ananyeva, M. N. Starovoytova, I. Z. Gaydukova, G. V. Lukina, E. V. Zonova, L. V. Eliseeva, G. F. Fatkhullina, D. I. Abdulganieva, D. G. Krechikova, T. V. Kropotina, O. B. Nesmeyanova, I. B. Vinogradova, E. S. Zhugrova, L. V. Ivanova, N. E. Nikulenkova, O. R. Ziganshin, T. V. Plaksina, M. V. Zlobin, Yu. Yu. Grabovetskaya, N. F. Soroka, O. B. Ershova, T. V. Povarova, O. N. Anoshenkova, A. A. Lutsky, A. V. Zinkina-Orikhan, Yu. N. Linkova, E. A. Fokina, A. A. Porozova, A. V. Eremeeva |
| |
| Vol 19, No 1 (2025) |
Is fibromyalgia secondary to rheumatic diseases? |
Abstract
PDF (Rus)
|
|
E. G. Filatova, N. A. Melikova, E. S. Filatova, A. M. Lila |
| |
| Vol 19, No 1 (2025) |
New possibilities for the treatment of systemic lupus erythematosus. How much does the effect cost? |
Abstract
PDF (Rus)
|
|
E. A. Pyadushkina, A. M. Lila, E. E. Yagnenkova, V. I. Ignatyeva, E. V. Derkach |
| |
| Vol 19, No 1 (2025) |
Assessment of muscle damage using magnetic resonance imaging data in dermatomyositis and sporadic inclusion body myositis |
Abstract
PDF (Rus)
|
|
A. A. Kolomeychuk, L. P. Ananyeva, L. V. Ptichkina, A. N. Khelkovskaya-Sergeeva, D. O. Kazakov |
| |
| Vol 19, No 1 (2025) |
The association between genetic characteristics and treatment failure when switching from biologic disease-modifying antirheumatic drugs/Janus kinase inhibitors in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Bobkova, A. M. Lila, A. E. Karateev, I. A. Guseva, E. Yu. Samarkina, M. V. Shabatina, N. V. Konovalova, D. A. Varlamov |
| |
| Vol 19, No 1 (2025) |
Body composition and skeletal muscles status in patients with rheumatoid arthritis during treatment with biologic disease-modifying antirheumatic drugs |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, M. V. Kozyreva, N. V. Demin, A. Yu. Feklistov, N. V. Toroptsova |
| |
| Vol 18, No 6 (2024) |
Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab |
Abstract
PDF (Rus)
|
|
A. V. Petrov, O. A. Pritulo, A. A. Petrov |
| |
| Vol 18, No 6 (2024) |
Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis |
Abstract
PDF (Rus)
|
|
M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova |
| |
| Vol 18, No 6 (2024) |
Possibilities of transposition of the extensores carpi tendons in the treatment of the rheumatoid hand |
Abstract
PDF (Rus)
|
|
A. V. Rozov, E. I. Byalik, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Results of a non-interventional multicenter observational study on the diagnosis and treatment of patients with axial psoriatic arthritis in rea-world clinical practice in the Russian Federation (NiSaXPA) |
Abstract
PDF (Rus)
|
|
T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. А. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov |
| |
| Vol 18, No 6 (2024) |
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment |
Abstract
PDF (Rus)
|
|
Eugen Feist, Roy M. Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S. Smolen |
| |
| Vol 18, No 6 (2024) |
Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III |
Abstract
PDF (Rus)
|
|
E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev |
| |
| Vol 18, No 6 (2024) |
Results of a three-year observation of the course of non-radiological axial spondyloarthritis |
Abstract
PDF (Rus)
|
|
Yu. Yu. Grabovetskaya, A. V. Smirnov, M. V. Cherkasova, A. A. Rudneva, A. M. Lila |
| |
| Vol 18, No 6 (2024) |
Association between the HLA-A, HLA-B, HLA-C and HLA-DRB1 gene alleles and Sjögren's syndrome with anti-Ro/SSA and anti-La/SSB autoantibodies production |
Abstract
PDF (Rus)
|
|
I. A. Guseva, M. D. Chanyshev, A. V. Torgashina, N. V. Vlasenko, Yu. I. Khvan, E. Yu. Samarkina, M. V. Shabatina, K. F. Khafizov |
| |
| Vol 18, No 6 (2024) |
Serum calprotectin in Behcet's disease |
Abstract
PDF (Rus)
|
|
K. S. Nurbaeva, M. V. Cherkasova, R. G. Goloeva, A. M. Lila, T. M. Reshetnyak |
| |
| Vol 18, No 5 (2024) |
Clinical characteristics of patients with chronic post-traumatic pain: data from a prospective study |
Abstract
PDF (Rus)
|
|
A. A. Bialik, A. E. Karateev, M. A. Makarov, V. А. Nesterenko, V. E. Bialik, E. I. Bialik |
| |
| Vol 18, No 5 (2024) |
Clinical and instrumental characteristics of osteoarthritis in hyperuricemia |
Abstract
PDF (Rus)
|
|
E. A. Taskina, A. M. Lila, L. I. Alekseeva, N. G. Kashevarova, K. M. Mikhailov, A. R. Halmetova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, D. M. Kudinskiy, T. A. Raskina, I. B. Vinogradova |
| |
| Vol 18, No 5 (2024) |
Clinical and immunologic abnormalities in COVID-19 |
Abstract
PDF (Rus)
|
|
A. K. Karibova, S. S. Akhmedkhanov, M. T. Kudae, H. M. Malaev |
| |
| Vol 18, No 5 (2024) |
Investigation of the analgesic efficacy of local therapy with non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis |
Abstract
PDF (Rus)
|
|
E. A. Strebkova, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, N. M. Savushkina, T. A. Korotkova, L. I. Alekseeva, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy |
Abstract
PDF (Rus)
|
|
P. A. Shesternya, A. A. Baranov, I. B. Vinogradova, O. N. Anoshenkova, O. V. Antipova, E. A. Bogdanova, Yu. Yu. Grabovetskaya, E. P. Ilivanova, A. N. Kalyagin, A. A. Blinova, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, N. M. Nikitina, N. V. Yudina, E. N. Alekseev, E. L. Nasonov, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis |
Abstract
PDF (Rus)
|
|
B. G. Issayeva, D. S. Dilmanova, A. S. Amanzholova, S. M. Issayeva, A. B. Kanapina, A. E. Turtaeva, G. Sh. Trimova |
| |
| Vol 18, No 5 (2024) |
Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis |
Abstract
PDF (Rus)
|
|
E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, E. L. Nasonov |
| |
| Vol 18, No 5 (2024) |
Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort |
Abstract
PDF (Rus)
|
|
A. A. Yanushonite, Yu. L. Korsakova, T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, M. M. Urumova, A. E. Dimitreva, S. I. Glukhova |
| |
| Vol 18, No 5 (2024) |
Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
D. A. Gerasimova, V. A. Gontarenko, E. V. Gerasimova, O. V. Zakharova, L. А. Lobuteva, T. V. Popkova, A. M. Lila |
| |
| Vol 18, No 5 (2024) |
Ultrasonography of the salivary glands in Sjögren's disease: own data analysis |
Abstract
PDF (Rus)
PDF (Eng)
|
|
Yu. I. Khvan, A. V. Torgashina, A. V. Volkov, S. I. Glukhov |
| |
| Vol 18, No 5 (2024) |
"Atherosclerotic" phenotype of rheumatoid arthritis. What do we know about it? |
Abstract
PDF (Rus)
|
|
A. V. Gordeev, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. N. Vorkel, T. M. Reshetnyak, K. S. Nurbaeva, M. V. Cherkasova, G. M. Tarasova, O. N. Egorova, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Multifunctional protein nucleobindin 1 as a marker of vascular damage in systemic lupus erythematosus |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Mikhailina, O. S. Kostareva, E. A. Aseeva, S. I. Glukhova, A. M. Lila, S. V. Tishchenko |
| |
| Vol 18, No 4 (2024) |
Long-term multicenter observational study of the drug Alflutop in Russia: use in patients with knee osteoarthritis (report 4) |
Abstract
PDF (Rus)
|
|
E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila |
| |
| Vol 18, No 4 (2024) |
Characteristics of clinical manifestations and pharmacotherapy in patients with rheumatoid arthritis requiring switching between biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. O. Bobkova, A. M. Lila, A. E. Karateev |
| |
| Vol 18, No 4 (2024) |
Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia |
Abstract
PDF (Rus)
|
|
Yu. L. Korsakova, L. D. Vorobyeva, E. E. Gubar, E. Yu. Loginova, P. O. Tremaskina, T. V. Korotaeva, A. E. Dimitreva, M. M. Urumova |
| |
| 1 - 100 of 445 Items |
1 2 3 4 5 > >>
|
